Why the study?
Does antifibrinolytic therapy reduce the incidence of secondary haemorrhage in patients following endoscopic prostatectomy?
Does antifibrinolytic therapy reduce the incidence of secondary haemorrhage in patients following endoscopic prostatectomy?
Antifibrinolytic therapy substantially reduces the incidence of secondary haemorrhage following endoscopic prostatectomy.
Answers are grounded in this paper and cite their sources.
Antifibrinolytic therapy merits consideration after endoscopic prostatectomy; confirms substantial haemorrhage reduction in this RCT.
This study examines the effect of antifibrinolytic therapy on the incidence of secondary haemorrhage following endoscopic surgery. One hundred consecutive patients were allocated randomly to treatment and control groups. The incidence of secondary haemorrhage was reduced from 56% in the control group to 24% in the treatment group.
No takes yet. Share an insight, caveat, or question.
Miller et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: